InvestorsHub Logo

jour_trader

04/01/24 9:38 AM

#398532 RE: HGilS #398530

Mikah was mentioned in my post.

Do you count CEO offloading overpriced drugs that never could make it to market as a win for Elite? Once again, see it as you will, but this is non-arms length. Never kosher from investor standpoint, unless you’re the CEO here, then there is extreme bias.

Pharma Sleuth

04/01/24 10:34 AM

#398540 RE: HGilS #398530

Which is where naltrexone and others came from...